• Home
  • Crypto
  • VARA Shuts Down Bitoasis: What Went Wrong?

VARA Shuts Down Bitoasis: What Went Wrong?

VARA-Mandated ‘Remedial Actions’: The Good and the Bad News

The Dubai digital assets regulator, VARA, has made a significant announcement regarding the crypto exchange Bitoasis. On the one hand, the regulator has deemed Bitoasis’ license for institutional and qualified retail investors “non-operational,” which is definitely bad news for the exchange. On the other hand, VARA has assured existing retail users that this decision will not affect their ability to use Bitoasis’ broker-dealer services.

Key Points:
– Bitoasis was issued a conditional MVP License, but it failed to meet the required conditions within the given timeframes.
– VARA has taken regulatory actions against Bitoasis as a result of their non-compliance.
– The regulator will continue to monitor the situation and assess Bitoasis’ fulfillment of the imposed remedial actions.
– Bitoasis clarifies that it has not yet started providing services due to the absence of a license from VARA.
– Existing retail users can still access Bitoasis’ broker-dealer services despite the non-operational license.

Hot Take: While VARA’s decision is undoubtedly a setback for Bitoasis, it’s reassuring to know that existing retail users can still rely on the exchange for their broker-dealer services. It remains to be seen how Bitoasis will address the regulator’s concerns and whether they will be able to regain their operational license.

Read Disclaimer
This content is aimed at sharing knowledge, it's not a direct proposal to transact, nor a prompt to engage in offers. Lolacoin.org doesn't provide expert advice regarding finance, tax, or legal matters. Caveat emptor applies when you utilize any products, services, or materials described in this post. In every interpretation of the law, either directly or by virtue of any negligence, neither our team nor the poster bears responsibility for any detriment or loss resulting. Dive into the details on Critical Disclaimers and Risk Disclosures.

Share it

VARA Shuts Down Bitoasis: What Went Wrong?